Medicine
Ziprasidone 20 mg/mL powder for injection
Ziprasidone 20 mg/mL powder for injection is a generic prescription medicine for intramuscular use, made by 8 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
NDC: 70518-4755-00 NDC: 70518-4755-01 OUTER PACKAGING: 10 in 1 CARTON…
Key facts
- Active ingredient (INN)
- Ziprasidone
- Brand
- Sold under the generic name
- Strength
- 20 mg/mL
- Dosage form
- Powder for injection
- Route
- Intramuscular
- Packs
- 1 vial, 10 vials, 10 pouches and 8 more
- Manufacturers
- Dr. Reddy's LaboratoriesIndiaSteriscience SpecialtiesIndiaGland PharmaIndiaNovadoz PharmaceuticalsIndiaFosun PharmaArmas PharmaceuticalsHealthFirstRemedyrepack
- Origin register
- US FDA, United States
- Storage
- NDC: 70518-4755-00 NDC: 70518-4755-01 OUTER PACKAGING: 10 in 1 CARTON PACKAGING: 1 mL VIAL SINGLE DOSE Ziprasidone mesylate for injection should be stored at 20° to 25°C (68° to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F) in dry form. Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N05AE04 Ziprasidone
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 26 December 2019
- Identifiers
- RxCUI 351223DailyMed set ID fa47c882-8286-467e-83f1-dfbff6216de3, b28a4f3d-0aae-050d-e053-2995a90aa4a6, 6fd6fc45-20c4-e223-3532-ce37aa02b71c +7NDC 70518-4755, 72266-160, 43598-061 +6Application ANDA211908, ANDA217595, ANDA216091
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 43598-061-58 | Dr. Reddy's LaboratoriesIndia | 22 March 2022 |
| 1 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 43598-848-58 | Dr. Reddy's LaboratoriesIndia | 24 February 2020 |
| 1 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 68083-340-01 | Gland PharmaIndia | 26 December 2019 |
| 10 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 72205-205-07 | Novadoz PharmaceuticalsIndia | 15 September 2022 |
| 1 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 82449-004-01 | Steriscience SpecialtiesIndia | 19 December 2025 |
| 10 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 82449-004-02 | Steriscience SpecialtiesIndia | 19 December 2025 |
| 10 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 72266-160-10 | Fosun Pharma | 15 June 2020 |
| 10 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 72266-160-42 | Fosun Pharma | 27 October 2020 |
| 10 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 72485-430-10 | Armas Pharmaceuticals | 21 September 2026 |
| 10 pouch in 1 case / 1 vial, single-dose in 1 pouch / 5 mL in 1 vial, single-dose | 51662-1564-3 | HealthFirst | 17 July 2021 |
| 10 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 70518-4755-0 | Remedyrepack | 17 September 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 5 February 2001 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Ziprasidone 20 mg/mL powder for injection.
Other strengths and forms of Ziprasidone
Clinical summary
Ziprasidone is an atypical antipsychotic indicated for the treatment of schizophrenia, among other approved uses. It is available as capsules and powder for injection for oral and intramuscular use. MedsAcross supplies Ziprasidone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ZiprasidoneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Geodon prescribing information (Viatris Specialty) · U.S. National Library of Medicine, DailyMed
Need Ziprasidone 20 mg/mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.